W.‐K. Hofmann

2.5k total citations
22 papers, 905 citations indexed

About

W.‐K. Hofmann is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, W.‐K. Hofmann has authored 22 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Genetics. Recurrent topics in W.‐K. Hofmann's work include Antifungal resistance and susceptibility (5 papers), Eosinophilic Disorders and Syndromes (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). W.‐K. Hofmann is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Eosinophilic Disorders and Syndromes (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). W.‐K. Hofmann collaborates with scholars based in Germany, Austria and United Kingdom. W.‐K. Hofmann's co-authors include B Dörken, G Moldenhauer, Reinhard Schwartz‐Albiez, Nicholas C.P. Cross, Andreas Reiter, Nicole Naumann, Karl Sotlar, Torsten Haferlach, Peter Valent and Alice Fabarius and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Oncogene.

In The Last Decade

W.‐K. Hofmann

21 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W.‐K. Hofmann Germany	15	304	248	203	194	186	22	905
Cathy Quilici Australia	16	698 2.3×	259 1.0×	97 0.5×	141 0.7×	77 0.4×	18	1.1k
Oliver Feyen Germany	16	460 1.5×	250 1.0×	57 0.3×	118 0.6×	117 0.6×	32	841
Noël Philippe France	13	341 1.1×	647 2.6×	66 0.3×	213 1.1×	171 0.9×	17	1.3k
Shunya Arai Japan	19	195 0.6×	678 2.7×	241 1.2×	629 3.2×	96 0.5×	51	1.3k
Sally M. Pittman Australia	15	206 0.7×	232 0.9×	292 1.4×	100 0.5×	34 0.2×	25	734
K A Siminovitch Canada	18	548 1.8×	353 1.4×	77 0.4×	89 0.5×	227 1.2×	22	1.2k
Yukiko Komeno Japan	20	189 0.6×	549 2.2×	131 0.6×	445 2.3×	102 0.5×	44	984
Patrizia Mella Italy	18	553 1.8×	238 1.0×	177 0.9×	199 1.0×	75 0.4×	29	1.2k
Laura C. Hooper United States	18	350 1.2×	371 1.5×	394 1.9×	72 0.4×	149 0.8×	24	1.1k
Dominic Borie United States	17	434 1.4×	207 0.8×	96 0.5×	102 0.5×	95 0.5×	46	1.0k

Countries citing papers authored by W.‐K. Hofmann

Since Specialization

Citations

This map shows the geographic impact of W.‐K. Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.‐K. Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.‐K. Hofmann more than expected).

Fields of papers citing papers by W.‐K. Hofmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.‐K. Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.‐K. Hofmann. The network helps show where W.‐K. Hofmann may publish in the future.

Co-authorship network of co-authors of W.‐K. Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of W.‐K. Hofmann. A scholar is included among the top collaborators of W.‐K. Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.‐K. Hofmann. W.‐K. Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boch, Tobias, Mark Reinwald, Birgit Spieß, et al.. (2018). Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study. Journal of Critical Care. 47. 198–203. 45 indexed citations

Henzler, Thomas, Dieter Buchheidt, John W. Nance, et al.. (2017). Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients. Scientific Reports. 7(1). 4483–4483. 31 indexed citations

Jawhar, Mohamad, Juliana Schwaab, Daniel Hausmann, et al.. (2016). Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis. Leukemia. 30(12). 2342–2350. 47 indexed citations

Boch, Tobias, Mark Reinwald, Oliver A. Cornely, et al.. (2015). Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA‐microarray from primary clinical samples. Mycoses. 58(12). 735–745. 28 indexed citations

Jawhar, Mohamad, Juliana Schwaab, Susanne Schnittger, et al.. (2015). Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. Leukemia. 29(5). 1115–1122. 98 indexed citations

Jawhar, Mohamad, Juliana Schwaab, Susanne Schnittger, et al.. (2015). Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis. Leukemia. 30(1). 136–143. 126 indexed citations

Schwaab, Juliana, Christian Dietz, Benjamin Hanfstein, et al.. (2014). Expression of transketolase-like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML). Journal of Cancer Research and Clinical Oncology. 140(3). 411–417. 3 indexed citations

Kripp, Melanie, Andreas Willer, Lothar R. Pilz, et al.. (2013). Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors. Annals of Hematology. 93(2). 317–325. 23 indexed citations

Chase, Andrew, Catherine Bryant, J Score, et al.. (2012). Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. Haematologica. 98(3). 404–408. 30 indexed citations

10.

Nolte, Florian, Britta Höchsmann, Aristoteles Giagounidis, et al.. (2012). Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload. Annals of Hematology. 92(2). 191–198. 64 indexed citations

11.

Reinwald, Mark, Michael Hummel, Birgit Spieß, et al.. (2012). Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. Journal of Antimicrobial Chemotherapy. 67(9). 2260–2267. 80 indexed citations

12.

Mochmann, Liliana H., Jutta Ortiz-Tánchez, Cornelia Schlee, et al.. (2011). Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG. Oncogene. 30(17). 2044–2056. 35 indexed citations

13.

Kasperk, C., H. J. Buhr, Friedhelm Raue, et al.. (2008). Endokrin aktive Epithelkörperchenzyste: Diagnose durch Bestimmung des intakten Parathormons in der Zystenflüssigkeit. DMW - Deutsche Medizinische Wochenschrift. 117(28/29). 1093–1096. 2 indexed citations

14.

Gilkes, Amanda, Ken Mills, Jesús María Hernández‐Rivas, et al.. (2007). C003 A molecular classification of leukaemia reveals MDS as a disease continuum with non-leukaemia and AML sub groups. Leukemia Research. 31. S24–S24. 2 indexed citations

15.

Staal, Frank J. T., Gunnar Cario, Giovanni Cazzaniga, et al.. (2006). Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia. 20(8). 1385–1392. 39 indexed citations

16.

Keilholz, Ulrich, Anne Letsch, W.‐K. Hofmann, et al.. (2006). Clinical and immune responses of WT1-peptide vaccination in patients with acute myeloid leukemia. Journal of Clinical Oncology. 24(18_suppl). 2511–2511. 7 indexed citations

17.

Hofmann, W.‐K., Seisho Takeuchi, Naoko Takeuchi, et al.. (2006). Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome. Leukemia Research. 30(11). 1347–1353. 12 indexed citations

18.

Ikezoe, Takayuki, Miller Cw, Seiji Kawano, et al.. (2001). Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.. PubMed. 61(13). 5307–10. 118 indexed citations

19.

Dierks, Marie‐Luise, et al.. (1993). [Needs for social medicine competence and developing social medicine competence--essentials for expert consultation].. PubMed. 55 Suppl 2. 54–6. 1 indexed citations

20.

Schwartz‐Albiez, Reinhard, B Dörken, W.‐K. Hofmann, & G Moldenhauer. (1988). The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoprotein.. The Journal of Immunology. 140(3). 905–914. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact